196 related articles for article (PubMed ID: 6418205)
21. The role of phospholipids in platelet function.
Morin RJ
Ann Clin Lab Sci; 1980; 10(6):463-73. PubMed ID: 6255856
[TBL] [Abstract][Full Text] [Related]
22. Phospholipids released from activated platelets improve platelet aggregation and endothelial cell migration.
Xiao H; Siddiqui RA; Al-Hassani MH; Sliva D; Kovacs RJ
Platelets; 2001 May; 12(3):163-70. PubMed ID: 11304418
[TBL] [Abstract][Full Text] [Related]
23. Changes in the organization of membrane lipids during human platelet activation. Study by fluorescent and freeze-fracture cytochemistry.
Lupu F; Calb M; Scurei C; Simionescu N
Lab Invest; 1986 Feb; 54(2):136-45. PubMed ID: 3945048
[TBL] [Abstract][Full Text] [Related]
24. Acid sphingomyelinase regulates platelet cell membrane scrambling, secretion, and thrombus formation.
Münzer P; Borst O; Walker B; Schmid E; Feijge MA; Cosemans JM; Chatterjee M; Schmidt EM; Schmidt S; Towhid ST; Leibrock C; Elvers M; Schaller M; Seizer P; Ferlinz K; May AE; Gulbins E; Heemskerk JW; Gawaz M; Lang F
Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):61-71. PubMed ID: 24233488
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological intervention with platelet phospholipase A2.
Nosal R; Jancinova V
Bratisl Lek Listy; 2001; 102(10):447-53. PubMed ID: 11802290
[TBL] [Abstract][Full Text] [Related]
26. Impaired factor X and prothrombin activation associated with decreased phospholipid exposure in platelets from a patient with a bleeding disorder.
Rosing J; Bevers EM; Comfurius P; Hemker HC; van Dieijen G; Weiss HJ; Zwaal RF
Blood; 1985 Jun; 65(6):1557-61. PubMed ID: 3995186
[TBL] [Abstract][Full Text] [Related]
27. Some antiphospholipid antibodies inhibit phospholipase A2 activity.
Schorer AE; Duane PG; Woods VL; Niewoehner DE
J Lab Clin Med; 1992 Jul; 120(1):67-77. PubMed ID: 1613330
[TBL] [Abstract][Full Text] [Related]
28. The effect of platelets upon factor Xa-catalyzed activation of factor VII in vitro.
Rao LV; Rapaport SI
Blood; 1988 Aug; 72(2):396-401. PubMed ID: 3135857
[TBL] [Abstract][Full Text] [Related]
29. Exposure of endogenous phosphatidylserine at the outer surface of stimulated platelets is reversed by restoration of aminophospholipid translocase activity.
Bevers EM; Tilly RH; Senden JM; Comfurius P; Zwaal RF
Biochemistry; 1989 Mar; 28(6):2382-7. PubMed ID: 2730870
[TBL] [Abstract][Full Text] [Related]
30. N-ethylmaleimide inhibits Ca2+ influx induced by collagen or arachidonate on rabbit platelets.
Sato T; Hashizume T; Fujii T
Biochim Biophys Acta; 1987 May; 928(3):266-71. PubMed ID: 3105597
[TBL] [Abstract][Full Text] [Related]
31. Differential hydrolysis of phospholipid molecular species during activation of human platelets with thrombin and collagen.
Takamura H; Narita H; Park HJ; Tanaka K; Matsuura T; Kito M
J Biol Chem; 1987 Feb; 262(5):2262-9. PubMed ID: 3102469
[TBL] [Abstract][Full Text] [Related]
32. Evidence that KF4939, a new anti-platelet agent, inhibits phospholipase activation in rabbit platelets: different aspects from cyclic AMP increasing agents and calmodulin antagonist.
Yamada K; Shuto K; Kubo K; Nakamizo N
Arch Int Pharmacodyn Ther; 1984 Mar; 268(1):141-54. PubMed ID: 6329114
[TBL] [Abstract][Full Text] [Related]
33. Selective inhibition of human platelet phospholipase A2 by buffering cytoplasmic calcium with the fluorescent indicator quin 2. Evidence for different calcium sensitivities of phospholipases A2 and C.
Simon MF; Chap H; Douste-Blazy L
Biochim Biophys Acta; 1986 Feb; 875(2):157-64. PubMed ID: 3080024
[TBL] [Abstract][Full Text] [Related]
34. Organization and role of platelet membrane phospholipids as studied with phospholipases A2 from various venoms and phospholipases C from bacterial origin.
Chap H; Perret B; Mauco G; Plantavid M; Laffont F; Simon MF; Douste-Blazy L
Toxicon; 1982; 20(1):291-8. PubMed ID: 7080042
[TBL] [Abstract][Full Text] [Related]
35. The effect of phospholipase C on human blood platelets.
Otnaess AB; Holm T
J Clin Invest; 1976 Jun; 57(6):1419-25. PubMed ID: 819457
[TBL] [Abstract][Full Text] [Related]
36. Collagen-induced exposure of anionic phospholipid in platelets and platelet-derived microparticles.
Thiagarajan P; Tait JF
J Biol Chem; 1991 Dec; 266(36):24302-7. PubMed ID: 1662206
[TBL] [Abstract][Full Text] [Related]
37. The anticoagulant effect of the human secretory phospholipase A2 on blood plasma and on a cell-free system is due to a phospholipid-independent mechanism of action involving the inhibition of factor Va.
Mounier C; Franken PA; Verheij HM; Bon C
Eur J Biochem; 1996 May; 237(3):778-85. PubMed ID: 8647125
[TBL] [Abstract][Full Text] [Related]
38. Evidence for a highly asymmetric arrangement of ether- and diacyl-phospholipid subclasses in the plasma membrane of Krebs II ascites cells.
Record M; El Tamer A; Chap H; Douste-Blazy L
Biochim Biophys Acta; 1984 Dec; 778(3):449-56. PubMed ID: 6509047
[TBL] [Abstract][Full Text] [Related]
39. Plasma membrane phospholipid integrity and orientation during hypoxic and toxic proximal tubular attack.
Zager RA; Sacks BM; Burkhart KM; Williams AC
Kidney Int; 1999 Jul; 56(1):104-17. PubMed ID: 10411684
[TBL] [Abstract][Full Text] [Related]
40. Phospholipase A2 activity in platelets of patients with primary thrombocythemia.
Vecino AM; Cesar JM; Navarro JL
Platelets; 2006 Aug; 17(5):332-5. PubMed ID: 16928606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
